LYSARC employs more than 170 engaged and qualified staff (MDs, PharmDs, PhDs, Engs, MBAs,…) having for lot of them, beyond their knowledge of the public research sector, a work experience in pharma, biotech and/or service companies.
Their activities are exclusively dedicated to lymphoma.
LYSARC operates, thanks to qualified staff and state-of-the-art equipment, together with LYSA experts, early-phase clinical trials, pathology, imaging and biology platforms.
LYSARC uses industry-grade tools to conduct clinical research projects..
The means which allow LYSARC to finance these resources mainly come from research collaborations with industrial partners and from public allowances. LYSARC accounts, regularly audited, are examined by an accountancy firm and are annually controlled by the General Assembly after consulting the Statutory Auditor.